Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care?

About this episode

Cristina Saura Manich discusses the potential for investigational approaches to improve first-line treatment for HER2-positive metastatic breast cancer.

Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care?

People in this episode

Guest: Cristina Saura Manich, MD, PhD

Topics covered

• HER2-Positive Metastatic Breast Cancer
• First-Line Treatment
• Investigational Approaches
• Standard of Care
• Oncology
• Breast Cancer

Keywords

• HER2-Positive
• Metastatic Breast Cancer
• First-Line Treatment
• Investigational Approaches
• Standard of Care
• Oncology
• Cancer Treatment

More episodes of PeerVoice Oncology & Haematology Audio

• Andrea Necchi, MD - Working With Our Patients as a Member of the MDT: A Bladder Cancer Awareness Month 2026 CME Initiative · June 9, 2026 · 21 min
• Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances Emerge · June 5, 2026 · 19 min
• Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer · June 5, 2026 · 20 min
• Marwan Fakih, MD - Making a Difference in Refractory Metastatic Colorectal Cancer: Practical Strategies to Positively Impact the Patient Journey Across Practice Settings · May 26, 2026 · 28 min
• Trisha Wise-Draper, MD, PhD - Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck Cancer · May 26, 2026 · 54 min
• Martin Köbel, MD - Scoring Folate Receptor-Alpha Expression in Gynecological Cancers: An Interactive Pathology Masterclass · May 18, 2026 · 30 min